Milestone Scientific INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

AMEX
Milestone Scientific Inc. files an amendment to its 2025 annual report to include previously omitted exhibits and new certifications.
AMEX
Milestone Scientific Inc. reported a net loss of $5.7 million for 2025, an improvement from 2024, but faces substantial doubt about its going concern ability and NYSE American listing compliance.
AMEX
Milestone Scientific's 2024 10-K filing reveals a decrease in revenue, continued operating losses, and efforts to secure additional funding while expanding its medical product line and distribution.
AMEX
Milestone Scientific modifies an executive's employment agreement regarding termination benefits and releases its annual report detailing financial performance and operational updates.